Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 22;12(5):673.
doi: 10.3390/jpm12050673.

The Promise of Nanotechnology in Personalized Medicine

Affiliations
Review

The Promise of Nanotechnology in Personalized Medicine

Maha Ali Alghamdi et al. J Pers Med. .

Abstract

Both personalized medicine and nanomedicine are new to medical practice. Nanomedicine is an application of the advances of nanotechnology in medicine and is being integrated into diagnostic and therapeutic tools to manage an array of medical conditions. On the other hand, personalized medicine, which is also referred to as precision medicine, is a novel concept that aims to individualize/customize therapeutic management based on the personal attributes of the patient to overcome blanket treatment that is only efficient in a subset of patients, leaving others with either ineffective treatment or treatment that results in significant toxicity. Novel nanomedicines have been employed in the treatment of several diseases, which can be adapted to each patient-specific case according to their genetic profiles. In this review, we discuss both areas and the intersection between the two emerging scientific domains. The review focuses on the current situation in personalized medicine, the advantages that can be offered by nanomedicine to personalized medicine, and the application of nanoconstructs in the diagnosis of genetic variability that can identify the right drug for the right patient. Finally, we touch upon the challenges in both fields towards the translation of nano-personalized medicine.

Keywords: nanomedicine; personalized medicine; pharmacogenetics; pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
A schematic representation of nanotechnology used in personalized medicine.
Figure 2
Figure 2
(a): Number of drugs in therapeutic areas; (b): biomarkers related to clinical therapeutics area anesthesiology; (c): biomarkers related to clinical therapeutics area cardiology; (d): biomarkers related to clinical therapeutics area hematology; (e): biomarkers related to clinical therapeutics area neurology; and (f): biomarkers related to clinical therapeutics area oncology.
Figure 3
Figure 3
Pharmacokinetics absorption, distribution, metabolism, and excretion (ADME) of personalized drugs or drugs combined with nanoparticles.
Figure 4
Figure 4
Overview of nanoparticles modifications to improve PK and PD properties.

References

    1. Personalized Medicine. [(accessed on 17 March 2022)]; Available online: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/person....
    1. Spear B.B., Heath-Chiozzi M., Huff J. Clinical application of pharmacogenetics. Trends Mol. Med. 2001;7:201–204. doi: 10.1016/S1471-4914(01)01986-4. - DOI - PubMed
    1. Auffan M., Rose J., Bottero J.-Y., Lowry G.V., Jolivet J.-P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. J. Nat. Nanotechnol. 2009;4:634–641. doi: 10.1038/nnano.2009.242. - DOI - PubMed
    1. Greish K. Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: Are we there yet? Drug Discov. Today Technol. 2012;9:e161–e166. doi: 10.1016/j.ddtec.2011.11.010. - DOI - PubMed
    1. Ventola C.L. The nanomedicine revolution: Part 1: Emerging concepts. Pharm. Ther. 2012;37:512.

LinkOut - more resources